Product Details
Rapid Test Kit Antigen Saliva Rapid Test Kit CoV-2 Antigen Saliva
Sample Rapid Test Kit Single Pack Rapid Test Kit
Intend Use
The rapid test kit is intended for the qualitative detection of
SARS-CoV-2 antigen in hunman saliva samples from novel coronavirus
suspected person with symptoms within 9 days from onset. It can be used for early triage and rapid management of suspected
populations, but it cannot be used as diagnosis basis of SARS-CoV-2
infection. Further nucleic acid detection should be carried out for suspected
population whose antigen test result is positive or negative.
Product Details
Item | Value |
Brand | Labnovation |
Name | SARS-CoV-2 Antigen Rapid Test Kit |
Model Number | LX-401601 |
Type | 1 Test / Kit |
Shelf Life | 24 Months |
specificity | 99.00% |
sensitivity | 94.29% |
Total Accuracy | 98.02% |
Quality Certification | CE, MSDS |
Sample Type | Saliva |
Sample volume | 3 Full drops |
Specification | 78*34*125 MM |
Product Feature
- Test results in 15 minutes
- No special/additional instruments required
- Suitable for occasion
- Lightweight and easy to carry
- Main Components
- Test Cassette
- Saliva Collector With Collection Tube
- Sample Extraction Buffer
- Package Insert
Use Step
- Open the cap of the collection tube and istall saliva collector.
- Put the collection tube with saliva collector close to lips and let
the saliva flow into the collection tube. Tje volum of saliva needs
to be half of 0.5 scal mark(0.25).
- Screw the sample extraction buffer carefully.
- Add all sample extration buffer to the collection tube. Discard the
saliva collector, tighten the cap onto the specimen collection
tube.
- Shake the specimen collection tube at least three time vigorously
to mix the saliva and the extraction buffer. Squeeze bottom of the
collection tube ensure the saliva is thoroughly mixed.
- Add 3 full drops of the solution to the sample well(S). Read the
result at 15 minutes. Do not interpret the result after 20 minutes.
Result Interpretation
POSITIVE: Two (2) distinct colored lines appear. One line should be in the
control region (C) and the other line should be in the test region
(T).
NEGATIVE: One (1) colored line appears in the control region(C). No apparent
colored line appears in the test region (T). The negative result
does not indicate the absence of analytes in the sample, it only
indicates the level of tested analytes in the sample is less than
the minimum detection limit.
INVALID: No colored lines appear, or control line fails to appear,
indicating that the operator error or reagent failure. Verify the
test procedure and repeat the test with a new testing device.
Virus Sources
Global high frequency mutation | Alpha / B.1.1.7(U.K.) | Beta I B.1.351(South Africa) |
Gemma I P.1(Brazil) | Kappa I B.1.617.1(India) | Delta I B.1.617.2(India) |
C.37,ect | Alpha I B.1.17(U.K.) | B.1.36.16.etc |
A.2.5,etc | A.23.1 | Alpha I B.1.17(U.K.) |
B.1.1.33.etc | C.1.1.etc. | else. |
Other Information
- This kit is a qualitative detection, which cannot determine the
exact content of antigen.
- The kit should be sealed and kept away from moisture. Reagents or
samples stored at low temperature should be balanced to room
temperature before using.
- Do not use samples that have been placed for longer than one hour
or contaminated.
- Waste should be treated in accordance with infectious substances
and should be discarded properly.
- The extraction reagent contains preservative agent which may be
toxic if ingested. When disposed of through a sink, flush with a
large volume of water.
- Keep away from children. Any child under age 13 shouldn’t perform
the test without parental guidance, or professional aid.
Certificate
Company Profile
Labnovation Technologies, Inc. is an original manufacturer
established in Shenzhen, China since 2001. We are dedicated in
developing and manufacturing IVD instruments and reagents including
HbA1c analyzer and reagents, rapid test reader & reagents,
hematology reagents, clinical chemistry reagents, electrolyte
reagents, wash solution and urine test reagents.
Labnovation products are developed in house, tested extensively in
clinics and passed strict quality controls. All of our products are
CE marked and approved by SFDA. In the past 15 years, our products
have been exported to 110 different countries and used in 8000
hospitals worldwide. We provide both ready-to-use final products
and bulk OEM reagents, including ready-to-use reagents,
concentrated, and powder.
With an investment of 10% of our annual sales into R&D, we
release new products every years. We win more and more domestic and international cooperation by
company reputation and products quality while we actively take part
in fairs like MEDICA,AACC, ARBA HEALTH and so on through which we
are well-known by the companies in this field.